EDGAR Filing Documents for 0001437749-17-015520

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-17-015520

Filing Date

2017-09-01

Accepted

2017-09-01 14:25:22

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	inbp20170630_10k.htm	10-K	1043714
2	EXHIBIT 21	ex21.htm	EX-21	5038
3	EXHIBIT 23.1	ex23-1.htm	EX-23.1	3434
4	EXHIBIT 31.1	ex31-1.htm	EX-31.1	15887
5	EXHIBIT 31.2	ex31-2.htm	EX-31.2	15824
6	EXHIBIT 32.1	ex32-1.htm	EX-32.1	6331
7	EXHIBIT 32.2	ex32-2.htm	EX-32.2	6778
	Complete submission text file	0001437749-17-015520.txt		5889766

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	inbp-20170630.xml	EX-101.INS	1173803
9	XBRL TAXONOMY EXTENSION SCHEMA	inbp-20170630.xsd	EX-101.SCH	58535
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	inbp-20170630_cal.xml	EX-101.CAL	50823
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	inbp-20170630_def.xml	EX-101.DEF	434875
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	inbp-20170630_lab.xml	EX-101.LAB	382512
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	inbp-20170630_pre.xml	EX-101.PRE	459893

Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205

Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816

INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)